CME, ICE Expected To Gain Most From OTC Regs
CME Group and IntercontinentalExchange stand to benefit the most from new derivatives regulations in the U.S., according to UBS.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts
